A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas

Por Strati, Paolo, Nastoupil, Loretta J., Davis, Richard E, Fayad, Luis E., Fowler, Nathan, Hagemeister, Fredrick B., Kwak, Larry, Oki, Yasuhiro, Wang, Michael, Westin, Jason, Ruben, Charnelle E., Wesson, Emily T., Piekarz, Richard, Fanale, Michelle A., Lee, Hun Ju
Publicado no Haematologica (2020)

A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma

Por Strati, Paolo, Chihara, Dai, Oki, Yasuhiro, Fayad, Luis E, Fowler, Nathan, Nastoupil, Loretta, Romaguera, Jorge E, Samaniego, Felipe, Garg, Naveen, Feng, Lei, Wesson, Emily T., Ruben, Charnelle E., Stafford, Mildred D., Nieto, Yago, Khouri, Issa F, Hosing, Chitra, Horowitz, Sandra B., Kamble, Rammurti T-., Fanale, Michelle A.
Publicado no Haematologica (2018)